Clinical Trials Browser

Completed × Gynecologic × Clear all

NCT04539327 2026-03-18

Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study

51 enrolled 28 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT05198804 2026-03-18

A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

Phase 1/2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06108479 2026-03-18

Study of DF6215 in Patients With Advanced Solid Tumors

Phase 1 Completed

DermatologicGenitourinaryGynecologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms

NCT02439034 2026-03-16

KETOCOL

Phase 2 Completed

GynecologicHead & Neck

Agnosia, Uterine Cervical Neoplasms, Head and Neck Neoplasms

NCT06144853 2026-03-16

The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study.

Peritoneal Neoplasms

NCT01247779 2026-03-13

ROBO-GYN

Phase NA Completed

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT03315351 2026-03-13

TEP-Curie

Phase NA Completed

Uterine Cervical Neoplasms

NCT07471113 2026-03-13

Mobile App-Supported HPV and Breast Cancer Awareness Program

Phase NA Completed

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms

NCT03239145 2026-03-12

Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor

Phase 1 Completed

62 enrolled 17 charts

DermatologicGastrointestinalGenitourinaryGynecologic

Kidney Neoplasms, Melanoma, Ovarian Neoplasms, Colorectal Neoplasms

NCT04300647 2026-03-12

SKYSCRAPER-04

Phase 2 Completed

172 enrolled 27 charts

Uterine Cervical Neoplasms

NCT04344899 2026-03-11

PORTS

Pelvic Neoplasms

NCT02867956 2026-03-10

Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms

NCT03367247 2026-03-10

BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal

Phase NA Completed

121 enrolled 16 charts

GastrointestinalGynecologic

Ascites, Gastrointestinal Neoplasms, Ovarian Neoplasms

NCT04341883 2026-03-10

Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms

NCT05494580 2026-03-10

Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer

Phase 1/2 Completed

Ovarian Neoplasms

NCT00040222 2026-03-09

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

BreastGynecologic

Breast Cancer, Familial, Breast Neoplasms, Hamartoma Syndrome, Multiple, Ovarian Neoplasms, Peutz-Jeghers Syndrome, Li-Fraumeni Syndrome, Risk Reduction Behavior

NCT00086567 2026-03-09

Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms

NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Phase 1/2 Completed

224 enrolled 15 charts

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

NCT04332653 2026-03-09

NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

Phase 1/2 Completed

215 enrolled 30 charts

BreastGastrointestinalGynecologicThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Thoracic Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT05162846 2026-03-09

MiGHT

Phase NA Completed

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT04423679 2026-03-06

SELFIE

Uterine Cervical Neoplasms

NCT06184867 2026-03-06

CATALYST

Phase NA Completed

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06820320 2026-03-06

Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy

Phase 2 Completed

Abdominal Neoplasms, Chylous Ascites, Pelvic Neoplasms

NCT05035173 2026-03-04

LYSA

Phase NA Completed

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT04415944 2026-02-27

HIPEC

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT06624878 2026-02-27

Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer

Phase NA Completed

Depression, Ovarian Neoplasms

NCT07439328 2026-02-27

ASTRA Study: Circulating Tumor Cells in Blood of Patients With High-Grade Serous Ovarian Cancer

Phase NA Completed

Ovarian Neoplasms

NCT04697628 2026-02-24

innovaTV 301

Phase 3 Completed

502 enrolled 18 charts 1 FDA

Uterine Cervical Neoplasms

NCT06711380 2026-02-24

Patient Ambassador

Phase NA Completed

Gynecologic Cancer

NCT03005743 2026-02-23

COMBAT-Cx

Phase NA Completed

Uterine Cervical Neoplasms

NCT04221945 2026-02-20

KEYNOTE-A18

Phase 3 Completed

1,060 enrolled 30 charts 1 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT02324062 2026-02-18

HCP

BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT07407179 2026-02-18

Quality of Life and Lymphedema After Surgical Treatment of Gynecological Malignancies

Phase NA Completed

Gynecologic Cancer

NCT04027868 2026-02-17

GREAT

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT05413811 2026-02-17

ACT2

Phase NA Completed

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms

NCT03579394 2026-02-10

CHRONO

Phase NA Completed

Ovarian Neoplasms

NCT05870787 2026-02-10

MEDIATOR

Uterine Cervical Diseases, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07393633 2026-02-10

Assessing Whole-body Metabolism in Gynecologic Cancers in Response to a Single Chemotherapy Cycle and/ or Immunotherapy

Ovarian Neoplasms, Uterine Neoplasms

NCT02195973 2026-02-09

Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer

Phase 1 Completed

Ovarian Neoplasms

NCT07398313 2026-02-09

PROP-CC

Phase NA Completed

Uterine Cervical Neoplasms

NCT01113112 2026-02-06

VEGF

Ovarian Neoplasms

NCT01279135 2026-02-06

PARCER

Phase 3 Completed

Uterine Cervical Neoplasms

NCT07376031 2026-02-06

Cervical Thermal Ablation to Treat Persistent HPV Infection

Phase NA Completed

Cervical Cancer Screening

NCT02749110 2026-02-05

PaCUDAHL-Gé

Phase NA Completed

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Patient Compliance

NCT03763838 2026-02-05

Acupressure for Fatigue in Ovarian Cancer Survivors

Phase NA Completed

171 enrolled 14 charts

Fatigue, Ovarian Neoplasms

NCT03635567 2026-02-04

KEYNOTE-826

Phase 3 Completed

617 enrolled 29 charts 1 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT03707574 2026-02-04

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

GastrointestinalGenitourinaryGynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT04457089 2026-02-04

Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer

Phase EARLY_PHASE1 Completed

Ovarian Neoplasms

NCT06662136 2026-02-03

The Effect of Motivational Interviewing on HPV-DNA Testing

Phase NA Completed

Uterine Cervical Neoplasms

NCT03884101 2026-02-02

LEAP-001

Phase 3 Completed

842 enrolled 25 charts

Endometrial Neoplasms